EPDR1 and cancer: In brief, eicosapentaenoic and docosahexaenoic acids can inhibit prostaglandin E2 production and secondary bile acids, thus exerting anti-inflammatory properties and altering proliferation and lipid metabolism of cancer cells.40 Similar properties have also been documented for EPDR1, which may hypothetically explain their interactions with CRC development.